Skip to content
GBC
  • ABOUT GBC
  • SOLUTIONS
  • PRODUCTS
  • R&D
  • INNOVATION
  • INVESTORS
  • MEDIA
  • English
    • 繁體中文
  • ABOUT GBC
  • SOLUTIONS
  • PRODUCTS
  • R&D
  • INNOVATION
  • INVESTORS
  • MEDIA
  • English
    • 繁體中文
  • 繁體中文
  • English

2025 Taiwan Excellence Award

GBC CellBio™ FX10 CTC System

Post navigation

Previous: 2024 SNQ Symbol of National Quality Certification
Next: 2025 US Edison Awards

近期文章

  • GBC July Revenue Reaches NT$24.63 Million, Up 57.82% YoY
  • GBC Showcases CLIA and AIO Platforms at WHX Bangkok, Expanding Opportunities in Southeast Asia
  • GBC 2025 EPS Reaches Record High of NT$7.46 as Trading Resumes, Advancing Transformation and Growth
  • GBC AI Biotech Building Officially Commissioned. Advancing AI Precision Medicine and Expanding Holistic Health Strategy.
  • GBC’s CellBio™ FX10 Receives 2024 SNQ Symbol of National Quality Certification

近期留言

No comments to show.

彙整

  • August 2026
  • July 2026
  • June 2026
  • May 2025
  • January 2025
  • December 2024
  • November 2024
  • April 2024
  • November 2023
  • July 2023
  • August 2022
  • July 2022
  • July 2020

分類

  • Press Releases
  • 未分類
  • About GBC
    • Our Story
    • Leadership
    • History
    • Award & Recognition
    • Locations
  • Solutions
    • COVID-19 Solution
    • Digital Pathology
    • CDMO by GBC
  • Products
    • IVD Solutions
    • Diagnostic Solutions
    • Blood Screening
    • IVD Biomaterials
  • Our Brands
    • GB Pharma
    • CurieMed
    • Danner Lab
  • R & D
    • Pharma
    • Diagnostic Solution
  • Innovation
  • ESG
  • Investors
    • About Us
    • Reporting
    • Corporate Governance
    • FAQ
  • Media
    • Press Release/Events
    • Award & Recognition
    • Marketing Downloads
  • Join Us
  • Contact Us
  • Documentation

Copyright © 2026 General Biologicals Corporation

  • Privacy Policy
  • Terms of Use
  • Facebook
  • YouTube
  • LinkedIn

Inquiry List